الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

medical purchasing solutions, llc - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. succinylcholine is contraindicated in persons with personal or familial history of malignant hyperthermia, skeletal muscle myopathies and known hypersensitivity to the drug. it is also contraindicated in patients after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, because succinylcholine administered to such individuals may result in severe hyperkalemia which may result in cardiac arrest (see warnings ). the risk of hyperkalemia in these patients increases over time and usually peaks at 7 to 10 days after the injury. the risk is dependent on the extent and location of the injury. the precise time of onset and the duration of the risk period are not known.

إيطاليا - الإيطالية - Ministero della Salute

green remedies spa -

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

renaissance pharma, inc. - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) - clobetasol propionate 0.5 mg in 1 g - clobetasol propionate foam is a corticosteroid indicated for treatment of moderate to severe plaque psoriasis of the scalp and mild to moderate plaque psoriasis of non-scalp regions of the body excluding the face and intertriginous areas in patients 12 years and older. none. there are no adequate and well-controlled studies in pregnant women. clobetasol propionate foam should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically. some corticosteroids have been shown to be teratogenic after dermal application to laboratory animals. clobetasol propionate has not been tested for teratogenicity when applied topically; however, it is absorbed percutaneously, and when administered subcutaneously, it was a significant teratogen in both the rabbit and the mouse. clobetasol propionate has greater teratogenic potential than steroids that are less potent. teratogenicity studi

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

renaissance pharma, inc. - penciclovir (unii: 359hue8fjc) (penciclovir - unii:359hue8fjc) - penciclovir 10 mg in 1 g - penciclovir cream is a nucleoside analog hsv dna polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in adults and children 12 years of age or older. penciclovir cream is contraindicated in patients with known hypersensitivity to the product or any of its components. category   b there are no adequate and well-controlled studies in pregnant women. animal data   no adverse effects on the course and outcome of pregnancy or on fetal development were noted in rats and rabbits following the intravenous administration of penciclovir at doses of 80 and 60 mg/kg/day, respectively (estimated human equivalent doses of 13 and 18 mg/kg/day for the rat and rabbit, respectively, based on body surface area conversion; the body surface area doses being 260 and 355x the maximum recommended dose following topical application of the penciclovir cream). because animal reproduction studies are not always predictive of human response, penciclovir should be used during pregnancy only if clear

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

renaissance pharma, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.25 mg in 1 g

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

renaissance pharma, inc. - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h) - clobetasol propionate 0.5 mg in 1 g - clobetasol propionate emulsion foam is indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years and older. none. teratogenic effects. pregnancy category c. there are no adequate and well-controlled studies of clobetasol propionate emulsion foam in pregnant women. clobetasol propionate emulsion foam should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. some corticosteroids have been shown to be teratogenic after dermal application to laboratory animals. clobetasol propionate has not been tested for teratogenicity when applied topically; however, it is absorbed percutaneously, and when administered subcutaneously, it was a significant teratogen in both the rabbit and the mouse. clobetasol propionate has greater teratogenic potential than steroids that a

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

renaissance pharma, inc. - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride 1 mg in 1 g - naftifine hydrochloride cream, 1% is indicated for the topical treatment of tinea pedis, tinea cruris and tinea corporis caused by the organisms trichophyton rubrum, trichophyton mentagrophytes, and epidermophyton floccosum. naftifine hydrochloride cream, 1% is contraindicated in individuals who have shown hypersensitivity to any of its components.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

renaissance pharma, inc. - permethrin (unii: 509f88p9sz) (permethrin - unii:509f88p9sz) - permethrin 50 mg in 1 g - permethrin cream, 5% is indicated for the treatment of infestation with sarcoptes scabiei (scabies). permethrin cream, 5% is contraindicated in patients with known hypersensitivity to any of its components, to any synthetic pyrethroid or pyrethrin.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

renaissance pharma, inc. - naftifine hydrochloride (unii: 25ur9n9041) (naftifine - unii:4fb1ton47a) - naftifine hydrochloride cream, 2% is indicated for the treatment of: interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organism trichophyton rubrum . none pregnancy category b. there are no adequate and well-controlled studies of naftifine hydrochloride cream, 2% in pregnant women. because animal reproduction studies are not always predictive of human response, naftifine hydrochloride cream, 2% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. the animal multiples of human exposure calculations were based on daily dose body surface area comparison (mg/m2 ) for the reproductive toxicology studies described in this section and in section 13.1. the maximum recommended human dose (mrhd) was set at 8 g 2% cream per day (2.67 mg/kg/day for a 60 kg individual). systemic embryofetal development studies were conducted in rats and rabbits. oral doses of 30, 100 and 300 mg/kg/day naftifine hydrochloride were administered during the period of o

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

renaissance pharma, inc. - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 20 mg in 1 g - erythromycin topical gel usp, 2% is indicated for the topical treatment of acne vulgaris. erythromycin topical gel usp, 2% is contraindicated in those individuals who have shown hypersensitivity to any of its components.